Previous 10 | Next 10 |
ACCESSWIRE news releases related Accesswire news releases and Accesswire press releases from 08/03/20 08:00:00 on US and Canada Markets.
LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3 rd - 6 th , 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. Kicking off the SNN Network Virtua...
Conference call and webcast scheduled for today, August 3, 2020 at 4:30 pm EDT BURLINGAME, CA / ACCESSWIRE / August 3, 2020 / Humanigen, Inc. , (OTCQB:HGEN) ("Humanigen"), announced today that the Company will host an investor call and webcast to discuss the National Institute of Hea...
LONDON, UK / ACCESSWIRE / August 3, 2020 / NQ Minerals Plc (AQSE:NQMI)(OTCQB:NQMLF)(US ADR OTCQB:NQMIY) ("NQ" or the "Company") announces that it has appointed international legal firm Hill Dickinson in London to prepare the necessary prospectus and documentation to have NQ's shares traded...
LONDON, UK / ACCESSWIRE / August 3, 2020 / NQ Minerals Plc (AQSE:NQMI)(OTCQB:NQMLF)(US ADR OTCQB:NQMIY) ("NQ" or the "Company") announces that it has appointed international legal firm Hill Dickinson in London to prepare the necessary prospectus and documentation to have NQ's shares traded...
This revised press release corrects the press release issued by The Eastern Company (NASDAQ:EML) at 8:00 a.m. ET on July 31, 2020. This revised press release is being issued solely to correct adjusted earnings per share and the calculation of adjusted earnings per share to present such items...
- First FDA approval of a second-line treatment for adult patients with relapsed or refractory DLBCL, helping fill a high unmet medical need - FDA granted Monjuvi Fast Track, Breakthrough Therapy and Priority Review designations - MorphoSys and Incyte will co-commercialize Monjuvi ...
PLANEGG & MUNICH, GERMANY / ACCESSWIRE / July 31, 2020 / MorphoSys AG (FSE:MOR)(Prime Standard Segment; MDAX & TecDAX)(NASDAQ:MOR) today announces that the U.S. Food and Drug Administration (FDA) has approved Monjuvi (R) (tafasitamab-cxix) in combination with lenalidomide for the ...
Company announces $157K revenue for Q1 LOS ANGELES, CA / ACCESSWIRE / July 31, 2020 / California Nanotechnologies Corp. ("Cal Nano" or the "Company")(TSXV:CNO)(OTC PINK:CANOF) is pleased to announce that revenue for the quarter ending May, 30, 2020 was $157,537. This represents an inc...
VANCOUVER, BC / ACCESSWIRE / July 31, 2020 / GLOBAL HEMP GROUP INC. (" GHG " or the " Company ") (CSE:GHG)(OTC PINK:GBHPF)(FRANKFURT:GHG) is pleased to announce that it will be making a rights offering (the " Rights Offering ") in which holders of record of the Company's common shares, as ...
WINNIPEG, MANITOBA / ACCESSWIRE / July 31, 2020 / Winston Gold Corp. (" Winston Gold " or the " Corporation ") (CSE:WGC)(OTCQB:WGMCF) announces the Board of Directors of the Corporation has granted a total of 3,000,000 incentive stock options to certain consultants of the Corporation to ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-1.43%Change Percent:
SILO Pharma Inc Company Name:
SILO Stock Symbol:
OTCMKTS Market:
silopharma.com Website: